PhaseRx, Inc. (PZRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 17, 2025
The Aaron's Company Market Cap
PhaseRx has a market cap or net worth of $1.17 thousand as of August 1, 2025. Its market cap has decreased by -96.67% in one year.
Market Cap
1.17K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 18, 2016, PhaseRx's market cap has decreased from 58.15M to 1.17K, a decrease of -100.00%. That is a compound annual growth rate of -69.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2025 | 1.17K | -49.98% |
| Dec 31, 2021 | 2.34K | -92.59% |
| Dec 31, 2020 | 31.61K | 285.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |